🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 15 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/05/2021 74,37 74,37 70,01 70,03 -6,09% 5,86% 1.438.800
07/05/2021 75,01 76,88 74,04 74,57 -0,05% 3,79% 1.091.100
06/05/2021 72,54 76,94 72,54 74,61 +2,53% 6,07% 2.102.600
05/05/2021 74,26 75,21 72,62 72,77 -1,69% 3,49% 981.500
04/05/2021 76,28 76,89 73,62 74,02 -4,01% 4,29% 1.466.000
03/05/2021 71,25 78,52 71,25 77,11 +8,85% 10,20% 3.112.500
30/04/2021 71,10 72,19 70,52 70,84 -0,80% 2,35% 797.700
29/04/2021 70,36 71,48 69,25 71,41 +1,94% 3,17% 710.000
28/04/2021 70,11 71,18 69,75 70,05 -0,65% 2,04% 578.700
27/04/2021 74,00 74,00 70,35 70,51 -3,81% 4,93% 748.400
26/04/2021 71,37 73,61 70,19 73,30 +3,33% 4,79% 703.800
23/04/2021 71,27 71,60 70,04 70,94 -0,62% 2,19% 784.400
22/04/2021 71,84 73,34 70,70 71,38 -1,08% 3,67% 834.400
21/04/2021 70,56 72,48 70,24 72,16 +1,21% 3,17% 499.300
20/04/2021 69,67 71,91 69,67 71,30 +1,39% 3,22% 651.500
19/04/2021 71,00 72,92 70,04 70,32 -2,06% 4,06% 711.200
16/04/2021 72,41 73,00 70,73 71,80 -1,14% 3,13% 670.400
15/04/2021 73,88 75,77 72,47 72,63 -1,09% 4,47% 717.400
14/04/2021 70,47 74,49 70,01 73,43 +4,91% 6,36% 1.238.500
13/04/2021 69,27 70,34 68,04 69,99 +0,88% 3,32% 1.104.900
12/04/2021 70,42 70,70 68,34 69,38 -1,64% 3,35% 1.151.600
09/04/2021 71,62 71,62 70,00 70,54 -1,29% 2,26% 781.600
08/04/2021 72,72 73,30 71,02 71,46 -0,52% 3,14% 819.500
07/04/2021 73,94 74,50 71,71 71,83 -2,84% 3,77% 745.100
06/04/2021 75,28 75,83 73,69 73,93 -2,22% 2,84% 666.000
05/04/2021 76,59 77,24 75,24 75,61 -0,79% 2,61% 662.900
01/04/2021 75,70 78,62 75,20 76,21 +2,25% 4,52% 994.100
31/03/2021 73,40 75,27 72,83 74,53 +1,96% 3,32% 1.230.700
30/03/2021 71,42 73,50 69,56 73,10 +1,18% 5,52% 1.528.400
29/03/2021 75,00 75,00 71,72 72,25 -3,38% 4,37% 1.020.500